Sean Parker’s cancer institute releases 1st research findings

San Francisco-based Parker Institute for Cancer Immunotherapy on April 10 published its first major scientific findings since launching in April 2016.

Advertisement

In the paper, published in Nature, scientists from Philadelphia-based University of Pennsylvania and New York City-based Memorial Sloan Kettering Cancer Center detail a new method to predict whether skin cancer patients will respond to certain immunotherapy treatments.

Silicon Valley entrepreneur and philanthropist Sean Parker, who co-founded Napster and served as Facebook’s founding president, founded the Parker Institute. Today, Mr. Parker serves as the organization’s chairman of the board.

Click here to view the full paper.

More articles on health IT:
5 things data scientists want hospital leaders to know
Metro Community Provider Network agrees to $400k HIPAA settlement
10 guidelines for ethical data research

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.